Oct 5 4 min Illumina’s $8bn Acquisition of GRAIL By Vinay Naik (University of Warwick), Roshni Padhi, Amarins Laanstra-Corn and Winston Shum (Stanford University) Overview of the deal Ac...
Sep 28 5 min Gilead Sciences Inc.’s $21bn Acquisition of Immunomedics By Jinghan Jennifer, Sanjana Ramaswamy, William Zhang (St Andrews), Mariana Velasco, Anthony Borgese, Mustafa Bayramli, Susan Xiao & Zen ...
Sep 14 4 min Nestlé's $2.6 Billion Acquisition of Aimmune Therapeutics By Edvard Bruu and Wilma Tillqvist (Stockholm School of Economics), Aman Singla, Akhil Anand Vajjhala and Siddharth Tripurani (New York U...
Sep 5 10 min Teladoc Health and Livongo Merger By: AJ Tomas (University of Chicago), Demi Akinjide, Saihejpal Ailwadhi, Ben Fobel, Zac Greenberg (University of Bristol) Overview of the...
Sep 7, 2019 7 min Mylan’s Merger with Pfizer’s Upjohn Unit Pfizer’s UpJohn franchise is merging with Mylan- the troubled EpiPen manufacturer shrouded in price fixing controversies.
Jul 27, 2019 7 min AbbVie’s $63 billion Acquisition of Allergan US drugmaker AbbVie launched a $63 billion bid for Botox maker Allergan in what will result in the world’s fifth largest drug company.
Jun 15, 2019 5 min Danaher $21.4bn acquisition of General Electric’s Life Sciences division General Electric sold its Life Sciences division to Danaher Corporation for $21.4bn, as part of GE's plan to push further its aviation.
May 8, 2019 4 min Roche’s $4.3 billion acquisition of Spark Roche, the Swiss drugs group, has won a two-way race to acquire Spark Therapeutics, Inc. for $4.8bn.
Mar 13, 2019 4 min Merck’s $2.4bn acquisition of Antelliq Merck's strategic acquisition of Antelliq leads the path to sustainable and significant investments in agricultural technologies.
Mar 9, 2019 5 min Eli Lilly’s $8bn Acquisition of Loxo Oncology Eli Lilly’s most recent acquisition marks a clear strategic path towards immunotherapy and oncology for the firm.
